These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2093302

  • 1. Effect of estramustine phosphate on free androgens. A comparative study of the effect of orchiectomy and estramustine phosphate on free androgens in patients with prostatic cancer.
    Van Poppel H, Werbrouck PW, Baert L.
    Acta Urol Belg; 1990; 58(4):89-95. PubMed ID: 2093302
    [Abstract] [Full Text] [Related]

  • 2. Effects of diethylstilbestrol and estramustine phosphate on serum sex hormone binding globulin and testosterone levels in prostate cancer patients.
    Karr JP, Wajsman Z, Kirdani RY, Murphy GP, Sandberg AA.
    J Urol; 1980 Aug; 124(2):232-6. PubMed ID: 7190620
    [Abstract] [Full Text] [Related]

  • 3. On the effects of oestrogen in the male. Some effects of different oestrogenic substances in rats and men with prostatic carcinoma.
    Daehlin L.
    Scand J Urol Nephrol Suppl; 1985 Aug; 91():1-44. PubMed ID: 3868029
    [Abstract] [Full Text] [Related]

  • 4. [Plasma testosterone and sex hormone transport globulin in patients with prostatic carcinoma under treatment].
    Daponte DP, Pidcock M, Robinson MR, Smith PH.
    Actas Urol Esp; 1982 Aug; 6(1):17-20. PubMed ID: 7200715
    [No Abstract] [Full Text] [Related]

  • 5. [The evaluation of the effect of Estracyt on prostatic cancer].
    Fukuoka H, Ishibashi Y, Sakai N, Ogawa T, Satomi Y, Sugawara T, Kamimura H, Yamaguchi T, Kishida K, Shirai K.
    Hinyokika Kiyo; 1991 Jan; 37(1):91-7. PubMed ID: 2011974
    [Abstract] [Full Text] [Related]

  • 6. [Estramustinphosphate in the treatment of prostatic cancer].
    Sánchez Gómez E, Pérez Pérez M, Huesa Martínez JI, Campoy Moreno JR.
    Arch Esp Urol; 1995 May; 48(4):365-7. PubMed ID: 7598547
    [Abstract] [Full Text] [Related]

  • 7. Some effects of orchiectomy, oestrogen treatment and radiation therapy in patients with prostatic carcinoma.
    Tomić R.
    Scand J Urol Nephrol Suppl; 1983 May; 77():1-37. PubMed ID: 6426040
    [Abstract] [Full Text] [Related]

  • 8. [Change of serum adrenal androgens in prostatic cancer patients after bilateral orchidectomy or LHRH agonist treatment].
    Oka H, Negoro H, Sugino Y, Iwamura H, Moroi S, Kawakita M.
    Hinyokika Kiyo; 2003 Sep; 49(9):521-5. PubMed ID: 14598689
    [Abstract] [Full Text] [Related]

  • 9. Multicenter phase 2 study of neoadjuvant paclitaxel, estramustine phosphate, and carboplatin plus androgen deprivation before radiation therapy in patients with unfavorable-risk localized prostate cancer: results of Cancer and Leukemia Group B 99811.
    Kelly WK, Halabi S, Elfiky A, Ou SS, Bogart J, Zelefsky M, Small E, Cancer Leukemia Group B.
    Cancer; 2008 Dec 01; 113(11):3137-45. PubMed ID: 18989865
    [Abstract] [Full Text] [Related]

  • 10. Androgens and prostate cancer risk: a prospective study.
    Wirén S, Stocks T, Rinaldi S, Hallmans G, Bergh A, Stenman UH, Kaaks R, Stattin P.
    Prostate; 2007 Aug 01; 67(11):1230-7. PubMed ID: 17562541
    [Abstract] [Full Text] [Related]

  • 11. [Complete androgen blockade (orchiectomy + flutamide) versus androgen blockade with cytostasis (orchiectomy + estramustine) in the treatment of virginal advanced prostate cancer].
    Flamm J, Fischer M.
    Wien Klin Wochenschr; 1988 Sep 09; 100(17):589-92. PubMed ID: 3055689
    [Abstract] [Full Text] [Related]

  • 12. Estramustine phosphate versus stilbestrol as primary treatment for metastatic cancer of the prostate.
    Nickel CJ, Morales A.
    Can J Surg; 1983 Sep 09; 26(5):434-8. PubMed ID: 6351988
    [Abstract] [Full Text] [Related]

  • 13. Influence of radical prostatectomy on serum hormone levels.
    Miller LR, Partin AW, Chan DW, Bruzek DJ, Dobs AS, Epstein JI, Walsh PC.
    J Urol; 1998 Aug 09; 160(2):449-53. PubMed ID: 9679896
    [Abstract] [Full Text] [Related]

  • 14. [Serum testosterone and acid phosphatase levels in patients with prostatic cancer treated with Estracyt].
    Németh A, Morvay J, Vécsei B.
    Orv Hetil; 1981 Apr 26; 122(17):1017-20. PubMed ID: 7022313
    [No Abstract] [Full Text] [Related]

  • 15. Reduced circulating androgen bioactivity in patients with prostate cancer.
    Raivio T, Santti H, Schatzl G, Gsur A, Haidinger G, Palvimo JJ, Jänne OA, Madersbacher S.
    Prostate; 2003 May 15; 55(3):194-8. PubMed ID: 12692785
    [Abstract] [Full Text] [Related]

  • 16. Redefining clinically significant castration levels in patients with prostate cancer receiving continuous androgen deprivation therapy.
    Morote J, Orsola A, Planas J, Trilla E, Raventós CX, Cecchini L, Catalán R.
    J Urol; 2007 Oct 15; 178(4 Pt 1):1290-5. PubMed ID: 17698136
    [Abstract] [Full Text] [Related]

  • 17. Weekly paclitaxel, estramustine phosphate, and oral etoposide in the treatment of hormone-refractory prostate carcinoma: results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA, Greco FA, Morrissey LH, Raefsky EL, Steis RG, Butts JA, Hainsworth JD, Minnie Pearl Cancer Research Network.
    Cancer; 2003 Nov 15; 98(10):2192-8. PubMed ID: 14601089
    [Abstract] [Full Text] [Related]

  • 18. [Clinical effects of estramustine phosphate disodium (Estracyt) on prostatic cancer].
    Nishio S, Kishimoto T, Maekawa M, Kawakita J, Hayahara N, Yuki K, Morikawa Y, Yasumoto R, Kato Y, Funai K.
    Hinyokika Kiyo; 1986 Nov 15; 32(11):1763-70. PubMed ID: 3825823
    [Abstract] [Full Text] [Related]

  • 19. Hormonal consequences of orchidectomy for carcinoma of the prostate. With special reference to the measurement of free testosterone in saliva and prostatic dihydrotestosterone levels.
    Boccon-Gibod L, Laudat MH, Guiban D, Steg A.
    Eur Urol; 1988 Nov 15; 15(1-2):99-102. PubMed ID: 3215246
    [Abstract] [Full Text] [Related]

  • 20. Adrenal steroid levels in castrated men with prostatic carcinoma treated with aminoglutethimide plus hydrocortisone.
    Ahmann FR, Crawford ED, Kreis W, Levasseur Y.
    Cancer Res; 1987 Sep 01; 47(17):4736-9. PubMed ID: 3621171
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.